The head of the US Food and Drug Administration said the agency will “take a hard look” at a gene therapy from Sarepta ...

The company had previously halted shipments to certain older patients following the deaths of two teenagers treated with the ...

Shares of Sarepta Therapeutics (NASDAQ:SRPT) continued to fall on Friday as Reuters reported that the U.S. FDA plans to ...

Good morning, and welcome to Sarepta's Conference Call to discuss the Update on Strategic Restructure and ELEVIDYS Label. As a reminder, today's program is being recorded. At this time, I'll turn the ...